Cargando…

A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.

Detalles Bibliográficos
Autores principales: Bullard, D. E., Thomas, D. G., Darling, J. L., Wikstrand, C. J., Diengdoh, J. V., Barnard, R. O., Bodmer, J. G., Bigner, D. D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1985
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977022/
https://www.ncbi.nlm.nih.gov/pubmed/3966985
_version_ 1782135174316687360
author Bullard, D. E.
Thomas, D. G.
Darling, J. L.
Wikstrand, C. J.
Diengdoh, J. V.
Barnard, R. O.
Bodmer, J. G.
Bigner, D. D.
author_facet Bullard, D. E.
Thomas, D. G.
Darling, J. L.
Wikstrand, C. J.
Diengdoh, J. V.
Barnard, R. O.
Bodmer, J. G.
Bigner, D. D.
author_sort Bullard, D. E.
collection PubMed
description
format Text
id pubmed-1977022
institution National Center for Biotechnology Information
language English
publishDate 1985
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19770222009-09-10 A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas. Bullard, D. E. Thomas, D. G. Darling, J. L. Wikstrand, C. J. Diengdoh, J. V. Barnard, R. O. Bodmer, J. G. Bigner, D. D. Br J Cancer Research Article Nature Publishing Group 1985-02 /pmc/articles/PMC1977022/ /pubmed/3966985 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Bullard, D. E.
Thomas, D. G.
Darling, J. L.
Wikstrand, C. J.
Diengdoh, J. V.
Barnard, R. O.
Bodmer, J. G.
Bigner, D. D.
A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.
title A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.
title_full A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.
title_fullStr A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.
title_full_unstemmed A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.
title_short A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.
title_sort preliminary study utilizing viable hla mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977022/
https://www.ncbi.nlm.nih.gov/pubmed/3966985
work_keys_str_mv AT bullardde apreliminarystudyutilizingviablehlamismatchedculturedgliomacellsasadjuvanttherapyforpatientswithmalignantgliomas
AT thomasdg apreliminarystudyutilizingviablehlamismatchedculturedgliomacellsasadjuvanttherapyforpatientswithmalignantgliomas
AT darlingjl apreliminarystudyutilizingviablehlamismatchedculturedgliomacellsasadjuvanttherapyforpatientswithmalignantgliomas
AT wikstrandcj apreliminarystudyutilizingviablehlamismatchedculturedgliomacellsasadjuvanttherapyforpatientswithmalignantgliomas
AT diengdohjv apreliminarystudyutilizingviablehlamismatchedculturedgliomacellsasadjuvanttherapyforpatientswithmalignantgliomas
AT barnardro apreliminarystudyutilizingviablehlamismatchedculturedgliomacellsasadjuvanttherapyforpatientswithmalignantgliomas
AT bodmerjg apreliminarystudyutilizingviablehlamismatchedculturedgliomacellsasadjuvanttherapyforpatientswithmalignantgliomas
AT bignerdd apreliminarystudyutilizingviablehlamismatchedculturedgliomacellsasadjuvanttherapyforpatientswithmalignantgliomas
AT bullardde preliminarystudyutilizingviablehlamismatchedculturedgliomacellsasadjuvanttherapyforpatientswithmalignantgliomas
AT thomasdg preliminarystudyutilizingviablehlamismatchedculturedgliomacellsasadjuvanttherapyforpatientswithmalignantgliomas
AT darlingjl preliminarystudyutilizingviablehlamismatchedculturedgliomacellsasadjuvanttherapyforpatientswithmalignantgliomas
AT wikstrandcj preliminarystudyutilizingviablehlamismatchedculturedgliomacellsasadjuvanttherapyforpatientswithmalignantgliomas
AT diengdohjv preliminarystudyutilizingviablehlamismatchedculturedgliomacellsasadjuvanttherapyforpatientswithmalignantgliomas
AT barnardro preliminarystudyutilizingviablehlamismatchedculturedgliomacellsasadjuvanttherapyforpatientswithmalignantgliomas
AT bodmerjg preliminarystudyutilizingviablehlamismatchedculturedgliomacellsasadjuvanttherapyforpatientswithmalignantgliomas
AT bignerdd preliminarystudyutilizingviablehlamismatchedculturedgliomacellsasadjuvanttherapyforpatientswithmalignantgliomas